Plant-based diet and survival among patients with metastatic colorectal cancer
Our study suggests that a plant-based diet, especially when rich in healthful plant foods, is associated with better survival among patients with metastatic CRC. The cause of survival benefits warrants further investigation.
Authors
- Chaoyuan Kuang (ORCID: https://orcid.org/0000-0002-8984-3906)
- Jeffrey A. Meyerhardt (ORCID: https://orcid.org/0000-0002-1120-0898)
- Chao Ma (ORCID: https://orcid.org/0000-0001-7741-818X)
- Charles D. Blanke
- Alan P. Venook (ORCID: https://orcid.org/0000-0001-9749-6548)
- En Cheng (ORCID: https://orcid.org/0000-0001-9523-9310)
- Heinz‐Josef Lenz (ORCID: https://orcid.org/0000-0003-2178-9568)
- Peter T. Campbell (ORCID: https://orcid.org/0000-0002-5549-2036)
- Fang‐Shu Ou (ORCID: https://orcid.org/0000-0003-1267-8735)
- Eileen Mary O'Reilly (ORCID: https://orcid.org/0000-0002-8076-9199)
- Kimmie Ng (ORCID: https://orcid.org/0000-0003-0631-1494)
- Bette J. Caan (ORCID: https://orcid.org/0000-0002-5803-310X)
- Clare A. Gatten
Institutions
- University of Southern California (US)
- Albert Einstein College of Medicine (US)
- Mayo Clinic (US)
- Memorial Sloan Kettering Cancer Center (US)
- Montefiore Medical Center (US)
- Kaiser Permanente (US)
- Oregon Health & Science University (US)
- University of California, San Francisco (US)
- Alliance for Clinical Trials in Oncology (US)
- USC Norris Comprehensive Cancer Center (US)
- Dana-Farber Cancer Institute (US)
- Mayo Clinic in Arizona (US)
- Alliance Data (United States) (US)
- SWOG Cancer Research Network (US)
- UCSF Helen Diller Family Comprehensive Cancer Center (US)
- Montefiore Einstein Comprehensive Cancer Center
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1093/jnci/djae213
- Citations
- 14
- Primary Topic
- Nutritional Studies and Diet
- Type
- article
- Field-Weighted Citation Impact
- 7.60
Funders
- Eli Lilly and Company
- Pfizer
- Sanofi
- National Institutes of Health
- Genentech
- National Cancer Institute